BioSpace News Archive

Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com (“Liberty” or the “Company”), a provider of high-quality cannabis, announced today that Victor Mancebo has resigned from the Board of Directors and his role as Chief Executive Officer, effective December 31, 2020.

How effective is mouthwash in preventing the spread of coronavirus? Independent lab analysis conducted at MRIGlobal’s accredited in vitro diagnostics laboratory for Rowpar Pharmaceuticals revealed promising findings.

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that it will report its third quarter 2020 financial and operating results on Wednesday, November 4, 2020, following the close of the U.S. financial markets. Lineage ma

Strive Health, a national innovator in value-based kidney care, announced that it has partnered with nearly 200 physicians and advanced practitioners from 20 nephrology groups across several states to participate in Medicare’s Comprehensive Kidney Care Contracting options of the Kidney Care Choices model.

NeuroEM Therapeutics is poised to deliver a knockout blow to Alzheimer’s disease. The clinical-stage medical device company is pleased to announce FDA Breakthrough Device designation for its bioengineered head device shown to reverse Alzheimer’s memory loss in its pilot study, published last fall in the Journal of Alzheimer’s Disease.

Abiomed announces the first two patients have been treated with the Impella ECP expandable percutaneous heart pump.

The Multiple Myeloma Research Foundation (MMRF) and Indapta Therapeutics announced a partnership to support the advancement of the company’s universal G-NK cell therapy into clinical trials for the treatment of patients with multiple myeloma

Emerging Preclinical and Clinical Data Support Potential of Mesenchymal Stem Cells (MSCs) to be Useful in COVID-19 and Acute Respiratory Distress Syndrome (ARDS) from Other Causes ImStem’s MSC Product Candidate IMS001 is Derived from AgeX’s Stem Cell Line ESI-053 IMS001, which Recently Gained FDA IND Clearance to Begin Human Study in Multiple Sclerosis, to be Considered for Development in COVID-19 and ARDS More Generally

Pulsara, the leading mobile telehealth and communication platform that connects healthcare teams across organizations, announced today that the company’s product Pulsara PATIENT has been honored as a 2020 EMS World Innovation Awards Winne

Synergis Software, a global leader in engineering information management and product data management (PDM), today announced that its flagship product, Adept, has earned 21 top placements in G2 Crowd’s Fall 2020 Grid Reports.